Showing results (141-150 of 340) with videos related to

Sort By:
Pageof 34
Dermatologic Clinics|May 22, 2003
Vaccines for viral diseases with dermatologic manifestationsMathijs H Brentjens, Kimberly A Yeung-Yue, Patricia C Lee, et al.
Proceedings (Baylor University. Medical Center)|October 28, 2022
Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)Sonali Batta, Austinn C Miller, Susuana Adjei, et al.
The Journal of Dermatological Treatment|September 13, 2018
A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasisFrancisco A Kerdel, Zoe D Draelos, Stephen K Tyring, et al.
Skin Therapy Letter|April 13, 2023
Antibiotic Resistance in Dermatology Part 2: Combating ResistanceAustinn C Miller, Susuana Adjei, Laurie A Temiz, et al.
Inflammopharmacology|March 3, 2026
A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trialsMartin Cevallos-Cueva, Chinenye Onejeme, Laura Ghanem, et al.
Dermatology Online Journal|September 1, 2010
Epidermodysplasia verruciformis after cutaneous T-cell lymphoma: Periungual presentationJonathan E Cutlan, Rashid M Rashid, Carlos Torres-Cabala, et al.
International Journal of Dermatology|December 12, 2018
Human polyomavirus 7 (HPyV7)-associated dermatoses: novel molecular mechanism driven by viral activation of 4E-BP1 and MEK-ERK-cJunJulie H Wu, Deepika Narayanan, Rebecca A Simonette, et al.
Expert Opinion on Pharmacotherapy|December 3, 2013
Varicella zoster: an update on current treatment options and future perspectivesSharon R Kim, Farhan Khan, Marigdalia K Ramirez-Fort, et al.
Journal of Drugs in Dermatology : JDD|October 27, 2018
A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart TreatmentStephen K Tyring, Theodore Rosen, Brian Berman, et al.
Clinical and Diagnostic Laboratory Immunology|September 3, 2002
Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cellsIstvan Arany, William E Whitehead, Kenneth J Grattendick, et al.
Pageof 34